FDA Requests Comments on Pediatric Postmarketing Pharmacovigilance and Drug Use Reviews

The FDA is collecting comments related to the pediatric postmarketing pharmacovigilance and drug utilization reviews of products posted between Sept. 17, 2016, and Feb. 24, 2017, including Aleve PM, Stepro, Ecoza, Etrea, Quartette, Truvada and Xerese.

The docket will be open Feb. 27 through March 10, 2017.